Jubilant Pharmova Subsidiary Receives GST Demand Order of ₹1.72 Crore

Jubilant Generics Limited, a wholly-owned subsidiary of Jubilant Pharmova Limited, has received a Refund cum rejection Order from the Assistant Commissioner, Central GST Division, Roorkee. The order c...

Jubilant Generics Limited, a wholly-owned subsidiary of Jubilant Pharmova Limited, has received a Refund cum rejection Order from the Assistant Commissioner, Central GST Division, Roorkee. The order confirms the demand and recovery of an erroneously sanctioned provisional refund amount, along with applicable penalty and interest. The GST demand totals ₹1,56,82,657, and the penalty amounts to ₹15,68,266, bringing the total to ₹1,72,50,923. The issue stems from an alleged incorrect calculation related to the provisional refund. The company believes the demand is legally incorrect and frivolous, as it was issued without a thorough examination of legal provisions, facts, and submitted documents. Jubilant Pharmova Limited is initiating the process to file an appeal before the Commissioner (Appeals) against this impugned demand order. The company is confident in its case on merits and will defend itself with documentary evidence. The company has stated that there will be no material impact on its financials, operations, or other activities due to this demand.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Jubilant Pharmova Limited in the news today?

Jubilant Pharmova Limited (JUBLPHARMA) is in the news due to the company has received a demand order from gst authorities for a refund amount, penalty, and interest, which is a negative development.

Litigation UpdatesRegulatory ImpactOther Regulatory Filings
Jubilant Pharmova LimitedJUBLPHARMAhttps://prysm.fi/v2/analyze/JUBLPHARMA

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Jubilant Pharmova Subsidiary Receives GST Demand Order of ₹1.72 Crore

December 27, 2025, 06:38 AM

AI Sentiment Analysis

Top Queries to Ask About Jubilant Pharmova Limited

Jubilant Generics Limited, a wholly-owned subsidiary of Jubilant Pharmova Limited, has received a Refund cum rejection Order from the Assistant Commissioner, Central GST Division, Roorkee. The order confirms the demand and recovery of an erroneously sanctioned provisional refund amount, along with applicable penalty and interest.

The GST demand totals ₹1,56,82,657, and the penalty amounts to ₹15,68,266, bringing the total to ₹1,72,50,923. The issue stems from an alleged incorrect calculation related to the provisional refund. The company believes the demand is legally incorrect and frivolous, as it was issued without a thorough examination of legal provisions, facts, and submitted documents.

Jubilant Pharmova Limited is initiating the process to file an appeal before the Commissioner (Appeals) against this impugned demand order. The company is confident in its case on merits and will defend itself with documentary evidence. The company has stated that there will be no material impact on its financials, operations, or other activities due to this demand.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Jubilant Pharmova Limited

Discover more trending news on Prysm

View All